DRNA - Dicerna Pharmaceuticals EPS misses by $0.02 misses on revenue May, 06 2021 04:21 PM Dicerna Pharmaceuticals Inc. Dicerna Pharmaceuticals (DRNA): Q1 GAAP EPS of -$0.39 misses by $0.02.Revenue of $47.6M (+39.9% Y/Y) misses by $1.46M.Press Release For further details see: Dicerna Pharmaceuticals EPS misses by $0.02, misses on revenue